FDA Approves New Drug to Reduce Cholesterol

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The Food and Drug Administration is meeting today to decide whether to approve an experimental drug that lowers bad cholesterol, and new findings suggest behavior therapy may help patients with chronic insomnia better than drugs.

Studies show patients who took a combination of the injectable experimental drug that is supposed to lower bad cholesterol  and a statin lowered their cholesterol up to 60 percent. That’s compared to 22 percent for patients taking a statin alone.

New findings suggest behavior therapy may help patients with chronic insomnia better than drugs. Researchers in Australia say the therapy works because it addresses the anxiety that often causes insomnia.

For more information, check out the video.

Sponsored by Mercy Health System.